These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 18166795)

  • 21. Diagnostic value of tryptase in anaphylaxis and mastocytosis.
    Schwartz LB
    Immunol Allergy Clin North Am; 2006 Aug; 26(3):451-63. PubMed ID: 16931288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-sensitivity flow cytometric analysis for the evaluation of systemic mastocytosis including the identification of a new flow cytometric criterion for bone marrow involvement.
    Pozdnyakova O; Kondtratiev S; Li B; Charest K; Dorfman DM
    Am J Clin Pathol; 2012 Sep; 138(3):416-24. PubMed ID: 22912359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis.
    Zanotti R; Bonifacio M; Lucchini G; Sperr WR; Scaffidi L; van Anrooij B; Oude Elberink HN; Rossignol J; Hermine O; Gorska A; Lange M; Hadzijusufovic E; Miething C; Müller S; Perkins C; Shomali W; Elena C; Illerhaus A; Jawhar M; Parente R; Caroppo F; Solomianyi O; Zink A; Mattsson M; Yavuz AS; Panse J; Varkonyi J; Doubek M; Sabato V; Breynaert C; Vucinic V; Schug T; Hägglund H; Wortmann F; Brockow K; Angelova-Fischer I; Belloni Fortina A; Triggiani M; Reiter A; Hartmann K; Malcovati L; Gotlib J; Shoumariyeh K; Niedoszytko M; Arock M; Kluin-Nelemans HC; Bonadonna P; Valent P
    Leukemia; 2022 Feb; 36(2):516-524. PubMed ID: 34545185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eosinophilia in systemic mastocytosis: clinical and molecular correlates and prognostic significance.
    Böhm A; Födinger M; Wimazal F; Haas OA; Mayerhofer M; Sperr WR; Esterbauer H; Valent P
    J Allergy Clin Immunol; 2007 Jul; 120(1):192-9. PubMed ID: 17451799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Systemic mastocytosis. Study of 14 cases].
    García-Erce JA; Giraldo P; de Vicente P; Alvarez R; Losfablos F; Velilla J; Mayayo P; Rubio-Félix D; Giralt M
    Med Clin (Barc); 1998 Oct; 111(13):499-502. PubMed ID: 9859067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimodal therapy for vertebral involvement of systemic mastocytosis.
    Krüger A; Hamann C; Brendel C; Ramaswamy A; Schnabel M; Neubauer A; Hofbauer LC
    Spine (Phila Pa 1976); 2009 Aug; 34(17):E626-8. PubMed ID: 19644322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum tryptase and SCORMA (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis.
    Heide R; van Doorn K; Mulder PG; van Toorenenbergen AW; Beishuizen A; de Groot H; Tank B; Oranje AP
    Clin Exp Dermatol; 2009 Jun; 34(4):462-8. PubMed ID: 19077102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
    Butterfield JH; Weiler CR
    Int Arch Allergy Immunol; 2008; 147(4):338-43. PubMed ID: 18622141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presentation of untreated systemic mastocytosis as recurrent, pulseless-electrical-activity cardiac arrests resistant to cardiac pacemaker.
    Butterfield JH; Weiler CR
    Int Arch Allergy Immunol; 2014; 163(2):130-4. PubMed ID: 24335343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis.
    Carter MC; Clayton ST; Komarow HD; Brittain EH; Scott LM; Cantave D; Gaskins DM; Maric I; Metcalfe DD
    J Allergy Clin Immunol; 2015 Dec; 136(6):1673-1679.e3. PubMed ID: 26044856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary N-methylhistamine as an indicator of bone marrow involvement in mastocytosis.
    Oranje AP; Mulder PG; Heide R; Tank B; Riezebos P; van Toorenenbergen AW
    Clin Exp Dermatol; 2002 Sep; 27(6):502-6. PubMed ID: 12372095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow-up of indolent mastocytosis in adults.
    Kors JW; Van Doormaal JJ; Breukelman H; Van Voorst Vader PC; De Monchy JG
    J Intern Med; 1996 Feb; 239(2):157-64. PubMed ID: 8568484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic mastocytosis: a diagnostic challenge.
    Bateman HE; Shroff V; Centeno LV; Bielory L
    Ann Allergy Asthma Immunol; 1995 May; 74(5):379-86. PubMed ID: 7749967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indolent systemic mastocytosis: a case and review of the current available treatment options.
    Lee Y; Wood P; Soyer HP
    Dermatol Online J; 2013 Jun; 19(6):18562. PubMed ID: 24011312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indolent systemic mastocytosis associated with atypical small lymphocytic lymphoma: a rare form of concomitant lymphoproliferative disease.
    Hauswirth AW; Födinger M; Fritz M; Müllauer L; Simonitsch-Klupp I; Streubel B; Chott A; Sperr WR; Jäger U; Valent P
    Hum Pathol; 2008 Jun; 39(6):917-24. PubMed ID: 18448146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of systemic mastocytosis with high-dose interferon-alfa: long-term follow-up of a case.
    Butterfield JH; Tefferi A; Kozuh GF
    Leuk Res; 2005 Feb; 29(2):131-4. PubMed ID: 15607359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Systemic mastocytosis as a cause of osteoporosis].
    Kemink SA; Smals AG; Kloppenborg PW
    Ned Tijdschr Geneeskd; 1996 Jun; 140(24):1277-9. PubMed ID: 8700283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The measurement of leukotrienes in urine as diagnostic option in systemic mastocytosis.
    Raithel M; Zopf Y; Kimpel S; Naegel A; Molderings GJ; Buchwald F; Schultis HW; Kressel J; Hahn EG; Konturek P
    J Physiol Pharmacol; 2011 Aug; 62(4):469-72. PubMed ID: 22100848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case report: pathologic long bone fracture in a patient with systemic mastocytosis.
    King JJ; Crawford EA; Iwenofu OH; Fox EJ
    Clin Orthop Relat Res; 2007 Jun; 459():263-9. PubMed ID: 17327804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aggressive systemic mastocytosis presenting with hepatic cholestasis.
    Kupfer SS; Hart J; Mohanty SR
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):901-5. PubMed ID: 17873616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.